- Home
- GNFT vs PVBC Comparison
GNFT vs PVBC Comparison
Compare GNFT & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- PVBC
- Stock Information
- Founded
- GNFT 1999
- PVBC 1913
- Country
- GNFT France
- PVBC United States
- Employees
- GNFT N/A
- PVBC N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- PVBC Major Banks
- Sector
- GNFT Health Care
- PVBC Finance
- Exchange
- GNFT Nasdaq
- PVBC Nasdaq
- Market Cap
- GNFT 172.2M
- PVBC 192.7M
- IPO Year
- GNFT 2019
- PVBC 2015
- Fundamental
- Price
- GNFT $3.61
- PVBC $11.27
- Analyst Decision
- GNFT Strong Buy
- PVBC Hold
- Analyst Count
- GNFT 1
- PVBC 1
- Target Price
- GNFT $13.00
- PVBC $12.00
- AVG Volume (30 Days)
- GNFT 3.8K
- PVBC 20.6K
- Earning Date
- GNFT 09-19-2024
- PVBC 01-31-2025
- Dividend Yield
- GNFT N/A
- PVBC N/A
- EPS Growth
- GNFT N/A
- PVBC N/A
- EPS
- GNFT 0.47
- PVBC 0.32
- Revenue
- GNFT $86,225,222.00
- PVBC $55,219,000.00
- Revenue This Year
- GNFT $145.20
- PVBC N/A
- Revenue Next Year
- GNFT N/A
- PVBC $5.90
- P/E Ratio
- GNFT $7.47
- PVBC $34.10
- Revenue Growth
- GNFT 175.45
- PVBC N/A
- 52 Week Low
- GNFT $3.35
- PVBC $7.36
- 52 Week High
- GNFT $6.42
- PVBC $12.32
- Technical
- Relative Strength Index (RSI)
- GNFT 47.76
- PVBC 62.46
- Support Level
- GNFT $3.35
- PVBC $10.82
- Resistance Level
- GNFT $3.66
- PVBC $11.16
- Average True Range (ATR)
- GNFT 0.11
- PVBC 0.26
- MACD
- GNFT 0.04
- PVBC 0.06
- Stochastic Oscillator
- GNFT 63.64
- PVBC 93.13
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.